The public review period for the 2020 Clinical Practice Guideline on Glomerular Diseases has now closed. Thank you for your candid comments and suggestions. Based on your input, we will prepare a final revised version for publication.
VIDEOS
COMMENTARIES
Canadian Society of Nephrology
Commentary on the 2012 KDIGO Clinical Practice Guideline for Glomerulonephritis
– Management of Nephrotic Syndrome in Children
– Management of Glomerulonephritis in Adults
KDOQI
US Commentary on the 2012 KDIGO Clinical Practice Guideline for Glomerulonephritis
KHA-CARI
Commentary on the 2012 KDIGO Clinical Practice Guideline for Glomerulonephritis
2012 GN Guideline Translations
Japanese
糸球体腎炎のためのKDIGO診療ガイドライン
German
KDIGO-Leitlinien zur Behandlung von Glomerulonephritiden
Russian (Full Text)
Практические клинические рекомендации KDIGO по лечению гломерулонефритов
Turkish (Full Text)
KDIGO GLOMERÜLONEFRİT KLİNİK UYGULAMA KILAVUZU
DISCLAIMER: USE OF THE CLINICAL PRACTICE GUIDELINES
This Clinical Practice Guideline is based upon the best information available at the time of publication. The recommendations are designed to provide information and assist decision-making. They are not intended to define a standard of care, and should not be construed as one. Neither should they be interpreted as prescribing an exclusive course of management. Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every health care professional making use of this Guideline is responsible for evaluating the appropriateness of applying them in the setting of any particular clinical situation. The recommendations for research contained within this document are general and do not imply a specific protocol.